Clinical Trial Update: IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

View source ↗

Summary

This clinical trial update outlines the implementation of the long-acting HIV treatment cabotegravir plus rilpivirine (CAB+RPV LA) for people with HIV in non-me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: University of Nebraska | Conditions: HIV | Status: ACTIVE_NOT_RECRUITING